Clinical and neuroradiological spectrum of metronidazole induced encephalopathy: Our experience and the review of literature

Journal of Clinical and Diagnostic Research

Volumn 10, Issue 6, 2016, Pages OE01-OE09

  Roy, Ujjawal ^a   Panwar, Ajay ^b   Pandit, Alak ^a   Das, Susanta Kumar ^a   Joshi, Bhushan ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Cerebellum; Corpus callosum; Magnetic resonance imaging; Nitroimidazoles; Toxicity

Indexed keywords

METRONIDAZOLE;

ATAXIA; BRAIN DAMAGE; BRAIN DISEASE; CLINICAL FEATURE; DIFFUSION WEIGHTED IMAGING; DRUG INDUCED DISEASE; DYSARTHRIA; DYSMETRIA; END STAGE LIVER DISEASE; FOLLOW UP; HEADACHE; HUMAN; MARCHIAFAVA BIGNAMI DISEASE; MENTAL HEALTH; METRONIDAZOLE INDUCED ENCEPHALOPATHY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NYSTAGMUS; REVIEW; SEIZURE;

EID: 84974691656     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2016/19032.8054     Document Type: Review

References (63)

1. Kusumi RK, Plouffe JF, Wyat RH, Fass RJ. Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med. 1980;93:59–60.
2. Frytak S, Moertel CG, Childs DS. Neurologic toxicity associated with high dose metronidazole therapy. Ann Intern Med. 1978;88:361–62.
3. Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. BMJ. 1977; 2:610–11.
4. Huang YT, Chen LA, Cheng SJ. Metronidazole-induced Encephalopathy: Case report and review literature. Acta Neurol Taiwan. 2012;21:74–78.
5. Iqbal SM, Murthy JG, Banerjee PK, Vishwanathan KA. Metronidazole ototoxicity--report of two cases. J Laryngol Otol. 1999;113(4):355-57.
6. De Bleecker JL, Leroy BP, Meire VI. Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity. Eur Neurol. 2005;53(2):93-95.
7. Knorr JP, Javed I, Sahni N, Cankurtaran CZ, Ortiz JA. Metronidazole-induced encephalopathy in a patient with end-stage liver disease. Case Rep Hepatol. 2012;2012:209258.
8. Ahmed A, Loes DJ, Bressler EL. Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology. 1995;45:588-89.
9. Horlen CK, Seifert CF, Malouf CS. Toxic metronidazole-induced MRI changes. Ann Pharmacother. 2000;34:1273–75.
10. Giannini AJ. Side effects of metronidazole. Am J Psychiatry. 1977;134(3):329-30.
11. Kuriyama A, Jackson JL, Doi A, Kamiya T. Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharmacol. 2011;34:241–47.
12. Gaye A, Sanghavi A. Metronidazole-induced encephalopathy in a pediatric patient. J Allerg Clin Immunol. 2007;119:S38.
13. Cantador AA, Meschia JF, Freeman WD, Tatum WO. Nonconvulsive status with metronidazole. Neurohospitalist. 2013;3:185-89.
14. Galvez M, Brahm J, Miranda M. Movement disorders as a manifestation of metronidazole-induced encephalopathy in a patient with chronic liver disease. Mov Disord. 2009;24:1864-66.
15. Yagi T, Shihashi G, Oki K, Suzuki S, Shinoda M, Itano O, et al. Metronidazole-induced encephalopathy and myoclonus: Case report and a review of the literature. Neurol Clin Neurosci. 2015;3:111-13.
16. Foreid H, Coelho M, Ferreira J, Ferro JM. Reversible iatrogenic subacute cerebellar syndrome, myoclonus and MRI findings following metronidazole administration. BMJ Case Rep. 2009;2009:bcr05.2009.1841.
17. Jafari G, Hosseini SM, Akhondzadeh S. Sudden hearing loss subsequent to diarrhea: what is the missing link? Daru. 2014;22(1):15.
18. Wright KH, Tyler JW. Recognizing metronidazole toxicosis in dogs. Vet Med. 2003;98:410–18.
19. Rao DN, Mason RP. Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs. J Biol Chem. 1987;262:11731-36.
20. Kim KH, Choi JW, Lee JY, Kim TD, Paek JH, Lee EJ, et al. Two cases of metronidazole-induced encephalopathy. Korean J Gastroenterol. 2005;45: 195-200.
21. Cecil KM, Halsted MJ, Schapiro M, Dinopoulos A, Jones BV. Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr. 2002;26(6):948–51.
22. Evans J, Levesque D, Knowles K, Longshore R, Plummer S. Diazepam as a treatment for metronidazole toxicosis in dogs: a retrospective study of 21 cases. J Vet Intern Med. 2003;17:304–10.
23. von Rogulja P, Kovac W, Schmid H. Metronidazole encephalopathy in rats. Acta Neuropathol (Berl). 1973;25:36-45.
24. Scharer K. Selective injury to Purkinje cells in the dog after oral administration of high-dose of nitroimidazole derivates [in German]. Verh Dtsch Ges Pathol. 1972;56:407–10.
25. Frasca D, Dahyot-Fizelier C, Adier C, Mimoz O, Debaene B, Couet W, et al. Metronidazole and hydroxymetronidazole central nervous system distribution: 1. microdialysis assessment of brain extracellular fluid concentrations in patients with acute brain injury. Antimicrob Agents Chemother. 2014;58(2):1019-23.
26. Dow SW, LeCouteur RA, Poss ML, Beadleston D. Central nervous system toxicosis associated with metronidazole treatment of dogs: five cases (1984-1987). J Am Vet Med Assoc. 1989;195(3):365-68.
27. Chacko J, Pramod K, Sinha S, Saini J, Mahadevan A, Bharath RD, et al. Clinical, neuroimaging and pathological features of 5-nitroimidazole-induced encephalo-neuropathy in two patients: Insights into possible pathogenesis. Neurol India. 2011;59:743–47.
28. Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. Am J Neuroradiol. 2007;28:1652-58.
29. Seok JI, Yi H, Song YM, Lee WY. Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps. Arch Neurol. 2003;60:1796-800.
30. Lee SS, Cha SH, Lee SY, Song CJ. Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging. J Comput Assist Tomogr. 2009;33:305-08.
31. Groothoff MV, Hofmeijer J, Sikma MA, Meulenbelt J. Irreversible encephalopathy after treatment with high-dose intravenous metronidazole. Clin Ther. 2010;32:60-64.
32. Heaney CJ, Campeau NG, Lindell EP. MR imaging and diffusion weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. AJNR Am J Neuroradiol. 2003;24:1615-17.
33. Bahn Y, Kim E, Park C, Park HC. Metronidazole induced encephalopathy in a patient with brain abscess. J Korean Neurosurg Soc. 2010;48:301-04.
34. Furukawa S, Yamamoto T, Sugiyama A, Ohira K, Aotsuka Y, Koide K, et al. Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci. 2015;352(1-2):129-31.
35. Geyer HL, Schaumburg HH, Herskovitz S. Methyl bromide intoxication causes reversible symmetric brainstem and cerebellar MRI lesions. Neurology. 2005;64:1279–81.
36. Shen WC, Chiu HH, Chow KC, Tsai CH. MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol. 1999;20(10): 1889-95.
37. Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology. 2003;45(6):393-99.
38. Malhotra HS, Garg RK, Vidhate MR, Sharma PK. Boomerang sign: Clinical significance of transient lesion in splenium of corpus callosum. Ann Indian Acad Neurol. 2012;15(2):151-57.
39. Chu K, Kang DW, Kim HJ, Lee YS, Park SH. Diffusion-weighted imaging abnormalities in Wernicke Encephalopathy: reversible cytotoxic oedema? Arch Neurol. 2002;59:123-27.
40. Engelbrecht V, Scherer A, Rassek M, Witsack HJ, Modder U. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology. 2002;222:410–18.
41. Erdener SE, Kansu T, Arsava EM, Dericioglu N. Brain MRI evolution of metronidazole intoxication. Neurology. 2013;80(19):1816-17.
42. Hobbs K, Stern-Nezer S, Buckwalter MS, Fischbein N, Finley Caulfield A. Metronidazole-induced encephalopathy: not always a reversible situation. Neurocrit Care. 2015;22(3):429-36.
43. Kim DW, Park JM, Yoon BW, Baek MJ, Kim JE, Kim S. Metronidazole induced encephalopathy. J Neurol Sci. 2004;224:107-11.
44. Kim DS, Jung JW, Kim JY, Kim JH, Kim EK, Kim SE. Reversible MRI findings in metronidazole-induced cerebellar dysfunction. J Korean Neurol Assoc. 1999; 17:904-07.
45. Dardzinski BJ, Sotak CH, Fisher M, Hasegawa Y, Li L, Minematsu K. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn Reson Med. 1993;30:318-25.
46. Cheong HC, Jeong TG, Cho YB, Yang BJ, Kim TH, Kim HC, et al. Metronidazole- induced encephalopathy in a patient with liver cirrhosis. Korean J Hepatol. 2011;17(2):157-60.
47. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2010;7(9):515-25.
48. Jang HJ, Sim SY, Lee JY, Bang JH. Atypical metronidazole-induced encephal opathy in anaerobic brain abscess. J Korean Neurosurg Soc. 2012;52(3): 273-76.
49. Uhl MD, Riely CA. Metronidazole in treating portosystemic encephalopathy. Ann Intern Med. 1996;124(4):455.
50. Woodruff BK, Wijdicks EF, Marshall WF. Reversible metronidazole-induced lesions of the cerebellar dentate nuclei. N Engl J Med. 2002;346(1):68-69.
51. Ito H, Maruyama M, Ogura N, Fujioka T, Iwasaki Y, Aikawa A, et al. Reversible cerebellar lesions induced by metronidazole therapy for Helicobacter pylori. J Neuroimaging. 2004;14(4):369-71.
52. Deenadayalu VP, Orinion EJ, Chalasani NP, Yoo HY. Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity. Clin Gastroenterol Hepatol. 2005;3(3):24.
53. Hammami N, Drissi C, Sebai R, Araar M, Maatallah Y, Belghith L, et al. Reversible metronidazole-induced encephalopathy. J Neuroradiol. 2007;34(2):133-36.
54. Sarna JR, Brownell AK, Furtado S. Cases: reversible cerebellar syndrome caused by metronidazole. CMAJ. 2009;181(9):611-13.
55. Graves TD, Condon M, Loucaidou M, Perry RJ. Reversible metronidazole- induced cerebellar toxicity in a multiple transplant recipient. J Neurol Sci. 2009; 285(1-2):238-40.
56. Kalia V, Vibhuti, Saggar K. Case report: MRI of the brain in metronidazole toxicity. Indian J Radiol Imag. 2010;20(3):195-97.
57. Khodakaram K, Barmano N. Uncommon reaction to a common prescription. Lancet. 2011;378:288.
58. Park KI, Chung JM, Kim JY. Metronidazole neurotoxicity: Sequential neuroaxis involvement. Neurol India. 2011;59:104-07.
59. Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y. Metronidazole-induced neurotoxicity developed in liver cirrhosis. J Clin Med Res. 2012;4(4):295-98.
60. Iqbal A, Tripathi K, Rai M, Dwivedi AD. Clinical and imaging perspective and unanswered questions in a case of metronidazole induced encephalopathy. Ann Indian Acad Neurol. 2013;16:569-71.
61. Godfrey MS, Finn A, Zainah H, Dapaah-Afriyie K. Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis. BMJ Case Rep. 2015;2015. pii: bcr2014206162.
62. Haridas A, Trivedi TH, Moulick ND, Joshi AR. Metronidazole-induced encephal opathy in chronic diarrhoea. J Assoc Phys India. 2015;63:77-79.
63. Senthilkumaran S, Shah S, Balamurugan N, Thirumalaikolundusubramanian P. Metronidazole encephalopathy: Uncommon reaction to a common drug. Int J Crit Illness Inj Sci. 2015;5(2):123-24.